Genetically engineered live-attenuated cytomegalovirus (CMV) vaccines improve pregnancy outcome in the guinea-pig model of congenital CMV infection

Registros relacionados

• Intravaginal cytomegalovirus (CMV) challenge elicits maternal viremia and results in congenital transmission in a guinea pig model
  por: Schleiss Mark R, et al.
  Publicado em: (2011-03-01)
• An Attenuated Cytomegalovirus Vaccine with a Deletion of a Viral Chemokine Gene Is Protective against Congenital CMV Transmission in a Guinea Pig Model
  por: Michael P. Leviton, et al.
  Publicado em: (2013-01-01)
• Cross Strain Protection against Cytomegalovirus Reduces DISC Vaccine Efficacy against CMV in the Guinea Pig Model
  por: K. Yeon Choi, et al.
  Publicado em: (2022-04-01)
• Analysis of the nucleotide sequence of the guinea pig cytomegalovirus (GPCMV) genome
  por: Cui Xiaohong, et al.
  Publicado em: (2008-11-01)
• Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model
  por: McGregor Alistair, et al.
  Publicado em: (2006-03-01)